Camden Partners

Growth equity investing since 1995.

[Camden Partners @CamdenPartners1]

Congratulations to Calvin Johnson (CJ) as he takes on his new role as CEO of Camden portfolio company,
@RoshalImaging! We’re very much looking forward to partnering with CJ who brings extensive leadership experience as well as a history of driving growth.

[Roshal Imaging Services @RoshalImaging]

Roshal Imaging is pleased to announce we have hired Calvin Johnson (CJ) as Chief Executive Officer, following a robust search process led by @CamdenPartners1. We’re looking forward to great things with him at the helm.
#ExecutiveLeadership #CEO #Healthcare

[Camden Partners @CamdenPartners1]

Congrats to Camden portfolio company @Catalyte_io on winning an @Inc Best in Business Award! Catalyte continues to transform software development with its use of #machinelearning & #predictiveanalytics to create a new, diverse generation of tech talent https://t.co/lgALhSJJ5r

[Camden Partners @CamdenPartners1]

@venmo adds 'Cash a Check' feature powered by Camden portfolio company, @IngoMoney, ahead of stimulus check #disbursements. Via @TechCrunch -- https://t.co/EFJ6sqpu3u #fintech

[Camden Partners @CamdenPartners1]

Camden Partners is excited to announce the recent closings of 3 new investments -- @eFileCabinet, @VollyTech, and Roshal Imaging Services. Be sure to check out the individual press releases ›› https://t.co/P3QIVJqBoB

[Camden Partners @CamdenPartners1]

Camden is excited to announce the final close on its sixth private equity fund, a $100M growth equity fund investing in technology-enabled services and software, education, and business services companies in the lower-middle market.

[Catalio Capital Management @CatalioCapital]

Excited to announce our participation in LifeSprout’s Series A round. LifeSprout is a ⁦@JohnsHopkins⁩ born biomaterials company, developing revolutionary products for aesthetic & regenerative medicine. https://t.co/WJnd2o8aWM

[Catalio Capital Management @CatalioCapital]

We are pleased to announce our investment in ⁦⁦@COMPASSPathway⁩ along with @foundersfund @ATAI_life & other great investors. In today's world, mental health is more important than ever, & COMPASS is leading the charge for next-gen therapies. https://t.co/ycNplIOP42

[Camden Partners @CamdenPartners1]

Camden is excited to announce the promotion of Calvin Young to Vice President! He has added value to a number of our existing portfolio companies and has been a key member of the deal team. Congratulations Calvin!

#movingonup #promotion #vicepresident #growth

[Camden Partners @CamdenPartners1]

Congrats to Camden's very own, @SukariBrown, for being selected for @HBCUvc's second class of the HBCUvc 31 Under 31 in Venture Capital List! Check out the complete list of 31  leaders >> https://t.co/y1Qpt5xT65 >> #emergingtalent

[Camden Partners @CamdenPartners1]

We're excited to announce the launch of our new website! Be sure to check out the newly designed https://t.co/zvNhogOOZJ! @CamdenNexus
#newwebsite #officiallylaunched #brandrefresh

[Camden Partners @CamdenPartners1]

We're proud to announce @CamdenNexus Co-Founder, @georgecpetro, was appointed to the Board of Directors of @KennedyKrieger Institute! <> https://t.co/i0nuYsWQD8

[Camden Partners @CamdenPartners1]

@CamdenNexus Venture Partner Bert Vogelstein and portfolio company @Thrive_Earlier Detection’s incredible work, focused on reliable early cancer diagnosis, featured in @FortuneMagazine

[Catalio Capital Management @CatalioCapital]

ICYMI, @FortuneMagazine wrote a fantastic article about Nexus Venture Partner Bert Vogelstein, portfolio company @Thrive_Earlier, and the emerging landscape of companies developing tests for early detection of cancer.
https://t.co/Hk6vWla89f

[Camden Partners @CamdenPartners1]

Be sure to stop by Camden’s photo booth at Beta City tonight! #betacity

[Camden Partners @CamdenPartners1]

Come join CP Partner, Jason Tagler, one of the judges at this year's Beta City Venture Capital Pitch Competition! We hope to see you there!
@betamore #betacity #citygarage

[Catalio Capital Management @CatalioCapital]

Congrats to Nexus Venture Partner Bert Vogelstein on being awarded the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for his role in discovering the genetic basis of cancer! @AlbanyMed @HHMINEWS @HopkinsMedicine

https://t.co/BSvvoO0u0L

[Catalio Capital Management @CatalioCapital]

.@ExactSciences, co-founded by Nexus Venture Partner Bert Vogelstein, announces the purchase of Genomic Health to add breast and prostate cancer tests to complement its breakthrough Cologuard test for colon cancer

https://t.co/Hn9iRJfCid

[Camden Partners @CamdenPartners1]

We're proud to congratulate Camden Operating Partner, @RichelleParham, for being recognized as one of @savoynetwork's 2019 Most Influential Women in Corporate America! ›› https://t.co/bweQQVXaII

[Catalio Capital Management @CatalioCapital]

New diagnostic tests developed by Nexus Venture Partner Bert Vogelstein at @HopkinsMedicine and licensed to Nexus portfolio company Thrive Earlier Detection could eliminate unnecessary surgery for patients with pancreatic cysts. https://t.co/WsQAVki3Bl

[Camden Partners @CamdenPartners1]

For the first time ever, majority of @MIT engineering department heads are women. We're proud of @CamdenNexus Venture Partner, Paula Hammond of @MITChemE, who is among this group of role models. #WomenInEngineering
https://t.co/KpfuSSNtmB

[Camden Partners @CamdenPartners1]

Exciting work by @CamdenNexus Venture Partners Elliot Fishman and Bert Vogelstein at @HopkinsMedicine and @hopkinskimmel on the next-generation of cancer screening through machine vision and artificial intelligence.
https://t.co/GkD6ux1ESe